In this issue:
Metastatic acral melanoma treatment outcomes
SLN biopsy positivity in ALM and other subtypes of cutaneous melanoma
Survival differences in ALM according to socioeconomic status and race
CAEs with metastatic melanoma treated with anti-CTLA4 and anti-PD-1
Chemotherapy after ICI failure in metastatic melanoma
Late-onset AEs of anti-PD-1 therapy in melanoma patients
Association of PTPRT mutations with ICI response and outcome in melanoma and NSCLC
Toripalimab + axitinib for metastatic mucosal melanoma
Detection of clinical progression through ctDNA in metastatic melanoma
Molecular characterisation of fast-growing melanomas
Please login below to download this issue (PDF)